Description:

Join the Querrey InQbation Lab for an informative seminar exploring the unique opportunities and challenges associated with building clinical data of already approved therapeutics. Aimed at principal investigators with promising preclinical data, this session will delve into the funding landscape for proof-of-concept clinical repurposing trials and highlight critical considerations for translating research into patient impact.

Topics will include:
- Strategies for securing funding for clinical-stage repurposing efforts, including Cures Within Reach funding RFPs
- Intellectual property (IP) protection options
- Understanding regulatory pathways with repurposed drugs as well as off-label dynamics
- Managing relationships with stakeholders, from pharma companies to patient/disease groups

This discussion will be particularly valuable for academic researchers considering next steps toward commercialization and clinical advancement.

Speaker
Clare Thibodeaux, PhD
Vice President of Scientific Affairs, Cures Within Reach

Dr. Clare Thibodeaux is Vice President of Scientific Affairs at Cures Within Reach, a nonprofit focused on improving patient outcomes through repurposing research - leveraging existing drugs, devices, and nutraceuticals to deliver treatments faster and more affordably. Clare brings deep expertise in scientific research, nonprofit leadership, and business strategy, with prior experience at a National Cancer Institute-designated cancer center and in market research across corporate, academic, and government sectors.

She holds a PhD in Tumor Biology from Georgetown University, an MBA from George Mason University, and a BA in Mathematics and German from the University of Michigan. Clare is passionate about advancing biomedical innovation through strategic funding, stakeholder engagement, and cross-sector partnerships.